Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep922 | Calcium and Bone | ECE2024

Anti-osteoporosis therapy after discontinuation of menopausal hormone therapy: a systematic review

Anagnostis Panagiotis , Divaris Efstathiios , Bosdou Julia , Tournis Symeon , Stathopoulos Konstantinos , Goulis Dimitrios

Objective: Menopausal hormone therapy (MHT) is efficacious in reducing the risk of vertebral, non-vertebral and hip fractures, irrespective of age, falls risk or baseline FRAX probability. However, the optimal sequential anti-osteoporotic treatment after MHT discontinuation has not yet been designated. This systematic review aimed to obtain the best evidence regarding the effect of antiresorptive or osteoanabolic treatment on bone mineral density (BMD) and/or fracture risk fol...